Fmr LLC Pmv Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 3,592 shares of PMVP stock, worth $5,459. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,592

Previous 2,527 42.14%

Holding current value

$5,459

Previous $4,000 25.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.51 - $2.21 $1,608 - $2,353	1,065 Added 42.14%	3,592 $5,000
Q1 2024 May 13, 2024	BUY	$1.51 - $3.12 $318 - $658	211 Added 9.11%	2,527 $4,000
Q4 2023 Feb 13, 2024	SELL	$1.23 - $6.6 $921 - $4,943	-749 Reduced 24.44%	2,316 $7,000
Q3 2023 Nov 13, 2023	BUY	$6.01 - $8.93 $2,139 - $3,179	356 Added 13.14%	3,065 $18,000
Q2 2023 Aug 11, 2023	BUY	$3.94 - $6.27 $1,749 - $2,783	444 Added 19.6%	2,709 $16,000
Q1 2023 May 11, 2023	BUY	$4.77 - $9.16 $7,088 - $13,611	1,486 Added 190.76%	2,265 $10,000
Q4 2022 Feb 13, 2023	SELL	$8.17 - $12.95 $6.31 Million - $10 Million	-772,317 Reduced 99.9%	779 $6,000
Q3 2022 Nov 10, 2022	BUY	$11.4 - $17.18 $513 - $773	45 Added 0.01%	773,096 $9.2 Million
Q2 2022 Aug 12, 2022	BUY	$9.23 - $22.43 $3.02 Million - $7.33 Million	326,932 Added 73.28%	773,051 $11 Million
Q1 2022 May 13, 2022	SELL	$14.86 - $23.55 $840,793 - $1.33 Million	-56,581 Reduced 11.26%	446,119 $9.29 Million
Q4 2021 Feb 14, 2022	SELL	$19.99 - $30.24 $3.03 Million - $4.59 Million	-151,700 Reduced 23.18%	502,700 $11.6 Million
Q3 2021 Nov 15, 2021	BUY	$26.84 - $36.58 $3.32 Million - $4.52 Million	123,686 Added 23.31%	654,400 $19.5 Million
Q2 2021 Aug 13, 2021	BUY	$28.01 - $36.01 $14.9 Million - $19.1 Million	530,714 New	530,714 $18.1 Million

Others Institutions Holding PMVP

# of Institutions

101

Shares Held

43.4M

Call Options Held

500

Put Options Held

100

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $69.3M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account